期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021; 31 (2)
Objective: The outcome of pediatric obsessive-compulsive disorder (OCD) is still unclear. In the present study, long-term rates and predictors of remi......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020; 30 (10)
Objectives:Placebo response is one of the most significant barriers to detecting treatment effects in pediatric (and adult) clinical trials focusing o......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020; 30 (6)
Objective: A recent pharmacoimaging study suggested that methylphenidate (MPH) and atomoxetine (ATX) might have common mechanisms for the treatment of......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020; 30 (5)
Background: Tic disorders (TDs) are chronic neuropsychiatric disorders that usually begin in childhood. Currently, antipsychotic drugs, such as aripip......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020; 30 (10)
Objectives: To evaluate the efficacy and safety of lurasidone in the treatment of children and adolescents with bipolar depression presenting with mix......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019; 29 (9)
Objectives: Premonitory urges (PUs) are defined as sensory experiences of pre-tic inner tension. Evidence suggests that most patients with Tourette sy......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019; 29 (9)
Objective: The high placebo response rate may hamper the discovery of antidepressants in children and adolescents with major depressive disorder (MDD)......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019; 29 (9)
Objective: A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted to assess the benefits and harms of vitamin D s......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018; 28 (3)
Objectives: This study aims to compare the prevalence of unlicensed and off-label use of antipsychotics among child and adolescent psychiatric outpati......
期刊： JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018; 28 (4)
Objective: To compare the efficacy and safety of olanzapine and risperidone in children and adolescents (aged <= 18 years) with psychosis by conduc......
